𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma

✍ Scribed by Alexandra Giatromanolaki; George P. Stathopoulos; Eleni Tsiobanou; Costandina Papadimitriou; Vassilios Georgoulias; Kevin C. Gatter; Adrian L. Harris; Michael I. Koukourakis


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
634 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND. The objective of this study was to evaluate intratumoral neoangiogenesis in Dukes Stage B and Stage C (AJCC/UICC Stage I and III) colorectal adenocarcinoma and its correlation with nuclear p53 oncoprotein accumulation and cytoplasmic bcl-2 expression as well as to assess the prognostic significance of these features in patient outcome. METHODS. Paraffin embedded specimens from 55 patients with Dukes Stage B (AJCC/UICC Stage I) and 51 patients with Dukes Stage C (AJCC/UICC Stage III) colorectal adenocarcinoma who were treated with surgery were assessed. Patients with lymph node involvement (Dukes Stage C [AJCC/UICC Stage III]) also were treated with postoperative pelvic radiotherapy and adjuvant chemotherapy with 5-fluorouracil and leucovorin with or without interferon-␣. Immunohistochemistry was performed using the anti-CD31 monoclonal antibody (MoAb) for vessel staining, the DO7 MoAb for nuclear p53 expression, and the clone 124 for cytoplasmic/ perinuclear bcl-2 expression. Patient follow-up ranged from 4 -70 months (median, 28 months).


πŸ“œ SIMILAR VOLUMES


Bcl-2 expression and prognosis of patien
✍ Noriaki Sakuragi; Toshihiro Ohkouchi; Hitoshi Hareyama; Ken Ikeda; Hidemichi Wat πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 194 KB πŸ‘ 2 views

Bcl-2 protein inhibits apoptosis, reduces the requirement for growth factors, and thereby extends the survival of cells. Recent findings of Bcl-2 in several solid tumors suggest that it might contribute to the genesis of some types of cancer. Over-expression of Bcl-2 might play a role in carcinogene

Combined analysis of p53 and vascular en
✍ Soon-Myoung Kang; Kiyoshi Maeda; Naoyoshi Onoda; Yong-Suk Chung; Bunzo Nakata; Y πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 326 KB πŸ‘ 2 views

Recent studies have demonstrated that the p53 tumor suppressor gene plays an important role in controlling tumor angiogenesis. We examined the expression of p53 and vascular endothelial growth factor (VEGF), a well-characterized angiogenic inducer, together with microvessel density to investigate th

Superficial radiotherapy for patients wi
✍ Beate Zagrodnik; Werner Kempf; Burkhardt Seifert; Beatrix MΓΌller; GΓΌnter Burg; M πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 218 KB

## Abstract ## BACKGROUND The histologic subtype of a basal cell carcinoma (BCC) may be an important factor for the success of a certain treatment modality. In the current article, the authors report recurrence rates among patients with BCC after superficial radiotherapy as well as Bcl‐2 and p53 e

Expression of bcl-2-, p53, and Ki-67 and
✍ Muneyuki Masuda; Atushi Shinokuma; Naoya Hirakawa; Torahiko Nakashima; Sohtaro K πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

## Background: Recent studies suggest that apoptosis is important in the cell death induced by treatment that damages deoxyribonucleic acid (dna). we assessed the correlation between the expression of the apoptosis-related proteins, p53 and bcl-2, and the clinical outcome of patients with nasophary

Prognostic significance of cyclooxygenas
✍ Sung-Chul Lim; Tae-Bum Lee; Cheol-Hee Choi; So-Yeon Ryu; Young-Don Min; Kyung-Jo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 257 KB

## Abstract ## Background Cyclooxygenase (COX)‐2 is believed to be an important enzyme related to the pathogenesis of colorectal cancer (CRC). p53 has been reported to be a negative regulator of COX‐2 expression in in vitro studies. The aim of this study was to investigate COX‐2 expression and its